HCPCS drug code · CMS crosswalk
Levalbuterol J-Code / HCPCS Code
In short
Levalbuterol is billed under HCPCS J7614 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg. One billing unit is 0.5 mg. CMS's crosswalk lists 16 Levalbuterol NDCs under this code.
Reference
- J7614
- Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mgBilling unit: 0.5 mg
- Labelers
- A-S Medication Solutions; Amneal Pharmaceuticals, LLC; Impax Laboratories, LLC; Mylan Pharmaceuticals Inc.; Ritedose Pharmaceuticals, LLC; Teva Pharmaceuticals USA, Inc.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Levalbuterol units and claim line
Enter the dose given to get the J7614 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Levalbuterol NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00093-4145-56 | J7614 | Teva Pharmaceuticals USA, Inc. | 30 × 3 | 19 |
| 00093-4146-56 | J7614 | Teva Pharmaceuticals USA, Inc. | 30 × 3 | 38 |
| 00093-4148-56 | J7614 | Teva Pharmaceuticals USA, Inc. | 30 × 3 | 75 |
| 00115-9930-78 | J7614 | Amneal Pharmaceuticals, LLC | 25 × 3 | 16 |
| 00115-9931-78 | J7614 | Amneal Pharmaceuticals, LLC | 25 × 3 | 32 |
| 00115-9932-78 | J7614 | Impax Laboratories, LLC | 25 × 3 | 63 |
| 00378-9690-52 | J7614 | Mylan Pharmaceuticals Inc. | 25 × 3 | 16 |
| 00378-9691-52 | J7614 | Mylan Pharmaceuticals Inc. | 25 × 3 | 32 |
| 00378-9692-52 | J7614 | Mylan Pharmaceuticals Inc. | 25 × 3 | 63 |
| 50090-6377-00 | J7614 | A-S Medication Solutions | 25 × 3 | 33 |
| 76204-0700-01 | J7614 | Ritedose Pharmaceuticals, LLC | 30 × 3 | 19 |
| 76204-0700-25 | J7614 | Ritedose Pharmaceuticals, LLC | 25 × 3 | 16 |
| 76204-0800-01 | J7614 | Ritedose Pharmaceuticals, LLC | 30 × 3 | 38 |
| 76204-0800-25 | J7614 | Ritedose Pharmaceuticals, LLC | 25 × 3 | 32 |
| 76204-0900-01 | J7614 | Ritedose Pharmaceuticals, LLC | 30 × 3 | 75 |
| 76204-0900-25 | J7614 | Ritedose Pharmaceuticals, LLC | 25 × 3 | 63 |
Levalbuterol: common questions
- What is the J-code for Levalbuterol?
- Levalbuterol is billed under HCPCS J7614 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg. One billing unit is 0.5 mg. CMS's crosswalk lists 16 Levalbuterol NDCs under this code.
- How many J7614 billing units are in a package of Levalbuterol?
- CMS lists 16 to 75 billing units per package, depending on the NDC, where one unit is 0.5 mg. Units to report are based on the dose given, not the package.
- Is J7614 a CPT code?
- No. J7614 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.
Other codes for the same drug
- J7607Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
- J7612Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
- J7615Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg